BrightSpec Announces Successful Field Trial for Diastereomer Analysis

Charlottesville, VA—July 7, 2017—BrightSpec, the first company to commercialize chemical analyzers based on molecular rotational resonance (MRR) spectroscopy, announced today the initial field trial deployment of its Microwave Cavity Spectrometer for continuous synthesis analysis.

The instrument utilizes the advanced analytics capabilities of MRR to directly measure diastereomer ratios on a chemical mixture, with no sample preparation or chromatography required.  The results flow from an 18-month collaboration with researchers at the University of Virginia and Virginia Commonwealth University, among others.  The ability to generate precise, at-line, diastereomer ratios in under 15 minutes enables medicinal chemists to monitor in-process chemical changes that affect drug purity, process control, and yield. Detailed results of the initial studies are forthcoming.

About BrightSpec

BrightSpec delivers stand-alone products for mixture analysis in R&D, pharmaceutical drug development and process control, fine chemicals, food and advanced manufacturing sectors.  BrightSpec received research funding from the US ARMY, the National Science Foundation, and the Virginia BioHealth Research Corporation. For more information, please contact Justin Neill (CTO) or Bob Lloyd (CEO) at 434-202-2391, or visit www.brightspec.com.